General article
Use of exercise challenge to investigate possible tolerance to beta-adrenoceptor stimulation in asthma

https://doi.org/10.1016/0007-0971(78)90042-6Get rights and content

Abstract

The effect of prolonged salbutamol administration on beta-adrenoceptor function in asthma has been examined. Six adult patients received salbutamol tablets (16 mg daily) for between 4 and 20 weeks and six adolescents received salbutamol aerosol (800 μg daily) for 2–5 weeks. Before and after the treatment period the acute bronchodilator response to inhaled salbutamol and the ability of inhaled salbutamol to protect against exercise-induced asthma were examined. Lymphocyte beta-adrenoceptor function was also measured in the patients on tablet therapy. Inhaled salbutamol was less effective in protecting against exercise-induced asthma at the end of the treatment period in the patients who had received tablet therapy, but otherwise there was no significant change in beta-receptor function of either airways or lymphocytes. This apparent loss of efficacy of inhaled salbutamol in the prevention of exercise-induced asthma in some subjects, even when its acute bronchodilator effect is preserved, might reflect differences in the susceptibility of different beta-adrenoceptors to desensitization after prolonged stimulation: its clinical importance remains uncertain.

References (27)

  • W.C. Alston et al.

    Response of leucocyte adenyl cyclase to isoprenaline and effect of alpha-blocking drugs in extrinsic bronchial asthma

    Br. med. J.

    (1974)
  • S.D. Anderson et al.

    Inhaled and oral salbutamol in exercise-induced asthma

    Am. Rev. resp. Dis.

    (1976)
  • P. Armitage

    Statistical Methods in Medical Research

  • Cited by (47)

    • Death due to asthma

      1996, Allergology International
    View all citing articles on Scopus

    Present address: University of Missouri Medical Center, Department of Child Health, Columbia, Missouri 65201, USA.

    View full text